Dr. Oz, the head of CMS, is now calling the plans "CHOICE Arrangements" and asking states to do more to support them.

In other words, the entry of biosimilars into a reference product's market does not guarantee patient savings. Benefit design ...

DeRemer had an inappropriate relationship with a DOL special agent and drank on federal property without proper authorization ...

A Milwaukee hospital alleges CVS used its control of a PBM, specialty pharmacy and third-party administrator to reduce ...

"Understanding the financial challenges LGBTQ+ adults face when accessing health care can help identify persistent gaps in ...

Nearly 70% of the estimate rests on payments above an insurer-calculated benchmark that a federal appeals court recently ...

This not only would be the fifth-consecutive year of elevated cost growth but also would be the largest annual increase since ...

The suits: The new settlement resolves four different federal overtime-pay suits. Each suit was filed on behalf of a group of nurses who had worked for Elevance subsidiaries in areas such as ...

Aon today announced plans to buy USI Insurance Services from KKR for $17 billion in cash. Aon executives talked about how ...

Simple Healthcare says one of the employers in its AI system test group learned it could cut spending by about 22% by capping ...

Those areas matter, but one of the more common and overlooked drivers of waste and clinical risk often hides in plain sight across everyday medications: therapy duplication, or situations in which a ...

The alleged price cuts jeopardize pharmacies' ability to serve their communities, according to Uthmeier's office. For example, a pharmacy outside Orlando saw its reimbursement for one drug drop 45%, ...